Page last updated: 2024-10-25

dequalinium and Breast Cancer

dequalinium has been researched along with Breast Cancer in 2 studies

Dequalinium: A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.
dequalinium : A quinolinium ion comprising decane in which one methyl hydrogen at each end of the molecule has been replaced by a 4-amino-2-methylquinolin-1-yl group.

Research Excerpts

ExcerptRelevanceReference
" The aim of the present study was to develop paclitaxel hybrid nanomicelles for oral administration to treat resistant breast cancer."7.88Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration. ( Cui, YN; Dian, LH; Hu, YJ; Lin, JY; Lu, WL; Su, ZB; Yan, Y; Zhang, JY, 2018)
" The aim of the present study was to develop paclitaxel hybrid nanomicelles for oral administration to treat resistant breast cancer."3.88Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration. ( Cui, YN; Dian, LH; Hu, YJ; Lin, JY; Lu, WL; Su, ZB; Yan, Y; Zhang, JY, 2018)
"Multidrug resistance (MDR) of breast cancer is the major challenge to successful chemotherapy while mitochondria-targeting therapy was a promising strategy to overcome MDR."1.48Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes. ( Chen, D; Hu, H; Li, J; Li, X; Pan, S; Qiao, M; Shi, M; Yang, C; Zhang, J; Zhao, X, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dian, LH1
Hu, YJ1
Lin, JY1
Zhang, JY1
Yan, Y1
Cui, YN1
Su, ZB1
Lu, WL1
Shi, M1
Zhang, J1
Li, X1
Pan, S1
Li, J1
Yang, C1
Hu, H1
Qiao, M1
Chen, D1
Zhao, X1

Other Studies

2 other studies available for dequalinium and Breast Cancer

ArticleYear
Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cytoc

2018
Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cholesterol; Cytochromes c; Dequalinium

2018